Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Oct 4, 2025
Transactions
33
Purchases
1
Sales
32
Purchase value
$1.19M
Sale value
$42.24M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Beckerle Mary CDirector
4Rule 10b5-1 plan disclosed
Filed Aug 12, 2026Period of report Aug 10, 20260000939767-26-000101
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 10, 2026
Common StockF1F2F3
9,812
$53.66
$526.51K
16,079
Direct
Filing footnotes · 3
F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.
F2Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $53.16 to $54.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Filed Jun 3, 2026Period of report Jun 1, 20260000939767-26-000085
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Eckhardt Sue GailDirector
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 1, 20260000939767-26-000084
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Aftab DanaEVP, Research and Development
4
Filed May 28, 2026Period of report May 26, 20260000939767-26-000070
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 26, 2026
Common StockF1
43,451
$50.35
$2.19M
594,741
Direct
Haley Patrick J.EVP, Commercial
4
Filed May 22, 2026Period of report May 20, 20260000939767-26-000069
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 20, 2026
Common StockF1F2
32,110
$49.81
$1.60M
357,638
Senner Christopher J.EVP and CFO
4
Filed May 19, 2026Period of report May 15, 20260000939767-26-000067
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 18, 2026
Common StockF3F2
34,901
$50.00
$1.75M
952,317
Hefti BrendaSVP and General Counsel
4Rule 10b5-1 plan disclosed
Filed May 19, 2026Period of report May 15, 20260000939767-26-000065
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Beckerle Mary CDirector
4
Filed May 8, 2026Period of report May 7, 20260000939767-26-000063
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 7, 2026
Common StockF1
7,712
$48.45
$373.65K
17,524
Direct
Freire Maria CDirector
4
Filed May 8, 2026Period of report May 7, 20260000939767-26-000062
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 7, 2026
Common StockF1
20,634
$46.00
$949.16K
100,819
Direct
Poste GeorgeDirector
4
Filed May 8, 2026Period of report May 7, 20260000939767-26-000061
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 7, 2026
Common StockF1F2
60,000
$45.71
$2.74M
118,832
Aftab DanaEVP, Research and Development
4
Filed Feb 26, 2026Period of report Feb 24, 20260000939767-26-000032
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 24, 2026
Common StockF1
47,918
$44.50
$2.13M
616,106
Direct
Aftab DanaEVP, Research and Development
4
Filed Feb 23, 2026Period of report Feb 19, 20260000939767-26-000031
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 19, 2026
Common StockF1
29,873
$44.35
$1.32M
664,024
Direct
Wyszomierski Jack LDirector
4Rule 10b5-1 plan disclosed
Filed Feb 20, 2026Period of report Feb 18, 20260000939767-26-000030
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Smith JulieDirector
4
Filed Feb 19, 2026Period of report Feb 17, 20260000939767-26-000029
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 18, 2026
Common StockF1
44,087
$44.50
$1.96M
20,590
Direct
Hefti BrendaSVP and General Counsel
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260000939767-26-000022
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Senner Christopher J.EVP and CFO
4
Filed Feb 18, 2026Period of report Feb 13, 20260000939767-26-000028
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 17, 2026
Common StockF4F2
30,617
$43.67
$1.34M
976,092
Haley Patrick J.EVP, Commercial
4
Filed Feb 18, 2026Period of report Feb 15, 20260000939767-26-000027
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 17, 2026
Common StockF3F2
3,036
$43.84
$133.10K
446,686
Eckhardt Sue GailDirector
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 13, 20260000939767-26-000025
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
Sale
Oliver BobDirector
4
Filed Feb 18, 2026Period of report Feb 13, 20260000939767-26-000023
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 13, 2026
Common StockF1
9,088
$43.61
$396.33K
42,282
Direct
Caligan Partners LPDirector · See Remarks
Johnson David EdwardDirector
4
Filed Nov 26, 2025Period of report Nov 25, 20250000902664-25-005164
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseNov 25, 2025
Common StockF1
27,532
$43.122
Haley Patrick J.EVP, Commercial
4
Filed Nov 24, 2025Period of report Nov 20, 20250000939767-25-000140
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 21, 2025
Common StockF5F2
28,043
$42.58
$1.19M
374,029
Papadopoulos SteliosDirector
4
Filed Nov 13, 2025Period of report Nov 12, 20250000939767-25-000137
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 12, 2025
Common StockF1F2
100,000
$43.55
$4.36M
1,189,228
Aftab DanaEVP, Research and Development
4
Filed Nov 13, 2025Period of report Nov 11, 20250000939767-25-000135
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 11, 2025
Common StockF1F2
48,383
$42.50
$2.06M
664,778
Beckerle Mary CDirector
4
Filed Nov 13, 2025Period of report Nov 11, 20250000939767-25-000134
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 11, 2025
Common StockF1
5,784
$42.03
$243.10K
40,218
Direct
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.
Jun 1, 2026
Common StockF1F2
3,925
$50.55
$198.41K
284,384
Direct
Filing footnotes · 2
F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
F2Includes 8,367 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025.
F2Represents the weighted average sales price. The shares of Exelixis, Inc. common Stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.73 to $50.61. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F1Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F2Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 26, 2026.
F1Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025.
F2Includes 403,915 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F3Represents the weighted average sales price. The shares of Common Stock were sold in multiple transactions at prices ranging from $50.00 to $50.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026.
F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, February 29, 2024, and February 26, 2025.
F2Includes 106,039 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs, the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs") and 167 shares of Common Stock acquired on April 30, 2026, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F3The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
F4Represents the weighted average sales price. The shares of Common Stock were sold in multiple transactions at prices ranging from $49.84 to $50.51. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026.
F1Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.
F1Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
F1Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $45.65 to $45.85. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2Includes 9,812 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F1Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F2Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 23, 2026.
F1Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F2Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 18, 2026.
F1Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F4The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
F1Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022.
F4The option, representing the right to purchase a total of 44,087 shares of Common Stock, became fully exercisable on June 1, 2023.
F5The option, representing the right to purchase a total of 20,030 shares of Common Stock, became fully exercisable on May 31, 2024.
F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.
F2Includes 95,956 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F3The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2026.
F1Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F3Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.
F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.66 to $43.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2026.
F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.
F2Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.80 to $43.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.50 to $43.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.89 to $43.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F1Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.
F1This Form 4 is filed by David Johnson ("Mr. Johnson") and Caligan Partners LP ("Caligan") with respect to the securities held by Caligan Partners Master Fund LP ("Caligan Master Fund"), a Cayman Islands limited partnership, and managed accounts ("Caligan Accounts", together with the Caligan Master Fund, the "Caligan Fund and Accounts") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
F2Includes 9,088 shares of common stock that will be issued to Mr. Johnson upon vesting of restricted stock units. Mr. Johnson is deemed to hold the securities reported herein for the benefit of the Caligan Fund and Accounts, and may, after vesting, if applicable, transfer the securities directly to the Caligan Fund and Accounts.
F1Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.10 to $42.13. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2Includes 374,029 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.
F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.87 to $41.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.77 to $41.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
F5Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.51 to $42.71. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
F1Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.55 to $43.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F1Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
F2Includes 431,306 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSU"). Each RSU is the economic equivalent of one share of Common Stock.
F3Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 10, 2025.
F1Includes 21,380 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.
